Reza Khorasaninejad

CEO @LEADOPTIK

[Ali Sadoughi @SadoughiAli]

Merging medicine’s timeless art with frontier science: Collaborating with @LeadOptik to embed OCT in biopsy tools→real-time, high-res imaging for earlier, more precise lung cancer detection. Sharper tools =better outcomes for patients. Thrilled for the future!#MedTech#LungCancer

[LEADOPTIK @LeadOptik]

Thrilled to share that LEADOPTIK has received FDA 510(k) clearance for our Last Inch Assessment™ (LIA) System for lung biopsy procedures.

Grateful to our incredible team, investors, advisors, and mentors for making this milestone possible.
https://t.co/HiE5uZaAS3

[Reza Khorasaninejad @rezakhoras]

@newscientist You can lose weight by drinking poison, losing weight is not the only goal, losing weight and staying healthy is and ultra processed food does not make you healthy.

[LEADOPTIK @LeadOptik]

Exciting news! 🎉 LEADOPTIK has been awarded key patents across the US, Europe, and Asia for our imaging probe & nanophotonic design—the core of our real-time, in-vivo tissue imaging system. IP is more than paperwork, it’s strategy! Read more: https://t.co/ttaNvuWwJl #DeepTech

[LEADOPTIK @LeadOptik]

From Kuala Lumpur to Harvard, Dr. @alexchee shares his journey & bold vision for the future of interventional pulmonology — where the “last inch” of the biopsy matters most. Why LIA is more than an upgrade: it’s a shift.
Read more: https://t.co/GprZfOsJze

[LEADOPTIK @LeadOptik]

Fitting In, Not Standing Out

In bronchoscopy, complexity is a given. That’s why simplicity matters.

LIA-1 fits in — with:
✔️ Familiar needle feel
✔️ Imaging that clarifies
✔️ Workflow that respects yours

Read more: https://t.co/jwOR3UnmXG
https://t.co/jwOR3UnmXG

[Reza Khorasaninejad @rezakhoras]

RT @LeadOptik: Access isn’t the challenge – it’s the last inch. LIA (Last Inch Assessment) uses Light, Optics, and Intelligence to transfor…

[LEADOPTIK @LeadOptik]

Turning on the lights in lung cancer diagnosis: Traditional biopsies lack real-time feedback. LIA changes that with light-based, in-vivo visualization, ending blind biopsies. The end of blind biopsy is coming. #LungCancer #LightBasedBiopsy
https://t.co/oRCduOknap

[LEADOPTIK @LeadOptik]

We are thrilled to share that we have raised $5 million in an oversubscribed Series Seed funding round. The funding was led by MetaVC Partners, with participation from @SOSV, @Sony_Innov_Fund, @TSVCap, ENEA, @arashf, @RayMuzyka, and others.
https://t.co/37JNXuHTm8

[LEADOPTIK @LeadOptik]

We are thrilled that @LeadOptik is named one of @hellotmrc's Deep Tech Pioneers!

[LEADOPTIK @LeadOptik]

We are excited to be one of the 2022 Execution Award finalists!

[LEADOPTIK @LeadOptik]

Here is our video for @MedTechAwards Best Video Competition. Like (on YouTube, link below) could help @LeadOptik win $10K. Appreciate your support!
https://t.co/hODW9dithP via @YouTube

[Creative Destruction Lab (CDL) @creativedlab]

Congratulations to @LeadOptik a venture-backed startup based in San Jose, California building miniature Lidar systems for surgical devices. They've graduated from CDL-Toronto Health! #CDLSuperSession
https://t.co/scVuOml30V

[Reza Khorasaninejad @rezakhoras]

@Amir_Safavi_N He was a great human being and he helped me in very difficult of my time at Waterloo and I know firsthand that he has helped numerous students… which is why it feels like losing a family member these two days for me…Condolence to you and your family Amir jan💔

[Reza Khorasaninejad @rezakhoras]

@bbiglar Thanks @bbiglar

[Reza Khorasaninejad @rezakhoras]

@SPIEevents @BrelyonHQ Thanks for spreading the words!

[Reza Khorasaninejad @rezakhoras]

@SPIEtweets My pleasure!

[Reza Khorasaninejad @rezakhoras]

Thanks @Orad

[Reza Khorasaninejad @rezakhoras]

Thanks, @SPIEtweets for sharing my story! https://t.co/NzUzgU9N7U